Form D · Other Health Care
Heart Test Laboratories, Inc.
Southlake, TX · CIK 0001468492
Offering snapshot reported Dec 7, 2023 · SEC filing
- Reported sold
- $1.09M Offering amount: $1.09M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 15, 2023 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,585,006 → $1,085,006
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 7, 2023 | Amendment | $1,085,006 | -$500,000vs Dec 4, 2023 | 2 | SEC filing |
| Dec 7, 2023 | Initial | $934,997 | No comparison | 1 | SEC filing |
| Dec 4, 2023 | Initial | $1,585,006 | No comparison | 2 | SEC filing |
| Sep 20, 2023 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Dec 28, 2021 | Initial | $2,000,000 | No comparison | 18 | SEC filing |
| Oct 15, 2021 | Initial | $640,000 | No comparison | 14 | SEC filing |
| Feb 19, 2021 | Initial | $1,100,000 | No comparison | 40 | SEC filing |
| Dec 11, 2019 | Initial | $3,897,504 | No comparison | 44 | SEC filing |
| Dec 11, 2019 | Initial | $6,493,155 | No comparison | 50 | SEC filing |
| Dec 11, 2019 | Initial | $138,000 | No comparison | 8 | SEC filing |
| Nov 7, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Sep 18, 2015 | Initial | Yet to sell | No comparison | 32 | SEC filing |
| Jul 17, 2015 | Initial | $4,211,000 | No comparison | 32 | SEC filing |
| Jul 30, 2009 | Initial | $1,600,000 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-498777
Represents 3,125,000 shares of common stock issued to a noteholder to pay off $500,000 drawn from a note and 3,656,388 shares of common stock issued to a noteholder to pay off principal and interest under a loan agreement.
Source: Form D, filed Dec 7, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Adams | Director |
| Bruce Bent | Director |
| Gary Chen | Director, Executive, Promoter |
| Drew Diaz | Director |
| Richard Gray | Director |
| Mark Hilz | Director, Executive |
| Markq Thomas Hilz | Executive |
| Kavy Jeffrey | Director |
| Patrick Kanouff | Director |
| John Owen | Director |
| Andrew Simpson | Director, Executive |
| Brian Szymczak | Director |
| Danielle Watson | Executive |
| David R. Wells | Director |
| Cheryl Yang | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
550 Reserve Street Suite 360
Southlake, TX, 76092
Southlake, TX, 76092